|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-1-15
|
|
pubmed:abstractText |
The aim of this phase II multicenter study was to evaluate the safety, toxicity and efficacy of docetaxel administered weekly as first line chemotherapy in patients with recurrent or metastatic endometrial cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
86-90
|
|
pubmed:meshHeading |
pubmed-meshheading:16996111-Adult,
pubmed-meshheading:16996111-Aged,
pubmed-meshheading:16996111-Aged, 80 and over,
pubmed-meshheading:16996111-Antineoplastic Agents,
pubmed-meshheading:16996111-Drug Administration Schedule,
pubmed-meshheading:16996111-Endometrial Neoplasms,
pubmed-meshheading:16996111-Female,
pubmed-meshheading:16996111-Humans,
pubmed-meshheading:16996111-Infusions, Intravenous,
pubmed-meshheading:16996111-Middle Aged,
pubmed-meshheading:16996111-Neoplasm Metastasis,
pubmed-meshheading:16996111-Neoplasm Recurrence, Local,
pubmed-meshheading:16996111-Taxoids
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Phase II study of weekly docetaxel in patients with recurrent or metastatic endometrial cancer: AGO Uterus-4.
|
|
pubmed:affiliation |
Georg-August-University, Dept. Obstet. and Gynaecol., Robert-Koch-Str. 40, 37075 Goettingen, Germany.
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
